Skip to content

TArget-Site Concentrations of prophylactic cefazolin in foot and Ankle surgery

TArget-Site Concentrations of prophylactic cefazolin in foot and Ankle surgery - TASCA-trial

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46781
Enrollment
24
Registered
2018-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'surgical site infection' 'postoperative wound infection'

Interventions

Group 1 receives a single dose of 1g of intravenously administered cefazolin, 30 minutes before surgery and group 2 receives a single dose of 2g of intravenously administered cefazolin, 30 minutes b

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - >17 years old - Undergoing open surgery of the foot or ankle

Exclusion criteria

Exclusion criteria: - Antibiotic treatment within 7 days before the surgery - An open fracture - A medical history of an allergic reaction to a cephalosporin or severe reaction to penicillin, or any other *-lactam antibiotic - Insufficient comprehension of the Dutch language to understand the patient information to make an informed decision to participate - Kidney disease (eGFR

Design outcomes

Primary

MeasureTime frame
Primary outcome: fT>MIC at the 'target-site'

Secondary

MeasureTime frame
Secondary outcome: fT>MIC in serum, rate of SSI, correlation between fT>MIC and infection

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)